Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,752 total articles
EyePoint plunged after a reported head-to-head miss of DURAVYU versus Eylea. The reaction looks outsized relative to the company's cash runway, the still-progressing clinical program, and heavy short positioning. We lay out a long trade with a strict stop and a long-term (46-180 trading days) horizon that targets recovery driven by trial nuance, sh…
Wendy's (WEN) is trading like a takeover candidate. With a $1.67B market cap, cheap multiples by some measures and outsized short interest, a bid led by Trian could deliver a meaningful premium. This trade idea outlines a concrete entry, stop and target for a swing trade (45 trading days) that aims to capture M&A upside while protecting against ong…
Kratos (KTOS) has shifted from a speculative technology story to a company delivering funded, production-scale defense systems. With a market cap near $11.5B, low leverage, sizable cash and a heavy backlog tied to unmanned systems and hypersonics, the equity looks actionable for a mid-term swing trade. The trade balances upside from contract conver…
SoundHound AI is a high-growth conversational AI play. Recent results show 45% YoY revenue growth and an upgraded full-year guide, but valuation is rich and the company still posts meaningful losses and cash burn. This trade idea offers a mid-term long with defined entry, target and stop to capture momentum while limiting downside if execution stum…
AppLovin (APP) has been punished despite strong revenue growth, exceptional margins and sizable free cash flow. I lay out three catalysts that could force a valuation re-rating, quantify the trade, and define precise entry, stop and target levels for a mid-term swing trade.
Shore Bancshares (SHBI) trades at a modest multiple with healthy capital metrics. Management's reported CRE portfolio average LTV below 50% and a low debt-to-equity ratio give the bank a strong cushion against localized commercial real estate stress. For risk-aware investors, a controlled long with a $23.50 entry, $21.00 stop and $28.00 target over…
GoGold (GLGDF) is trading near its 52-week highs after a steady technical run and improving volume profile. The company operates the Parral Tailings operation and holds the Los Ricos exploration complex, giving a mix of immediate cash flow and upside optionality. With a $1.25B market cap, rising moving averages, bullish MACD and active short intere…
Whitecap's increasing exposure to Veren-style assets improves realized pricing and free cash flow potential; this trade targets a mid-term re-rating tied to outperformance on volumes and margins.
Remitly (RELY) has converted scale into profitability and a rapidly growing customer base. At roughly $25.10 today and a market cap near $5.3B, the stock offers an asymmetric trade: modest valuation, accelerating fundamentals, and clear revenue-expansion levers — balanced by competitive and regulatory threats. This trade targets a $30.00 upside in …
Hermes has been sold off on cyclical concerns and short-term liquidity worries. The market is overlooking durable pricing power, direct-to-consumer control and inventory discipline that should support earnings and margins over the next 45 trading days. This trade idea lays out an actionable long with precise entry, stop and target levels and clear …
Lumentum’s revenue and adjusted EPS momentum, outsized supply commitments from hyperscalers, and a favorable technical setup make this an actionable long. I lay out entry, stop, and target levels for a mid-term swing while addressing valuation and material risks.
AstraZeneca ($AZN) is trading roughly 24% below its 52-week high and offers a reasonable entry for a mid-term swing trade. The company still generates free cash flow ($2.275B) and delivers strong ROE (16.4%), but large leverage and expensive enterprise multiples cap upside. This trade aims to capture mean reversion while protecting capital if trial…
Acadia Healthcare is expanding capacity into high-demand behavioral health segments while trading at an EV/EBITDA below 9 and a market cap of roughly $2.6B. Operational and legal headlines have pressured the stock, but a disciplined long with a clear stop can capture upside as new beds and outpatient capacity come online over the next six months.
Pagaya Technologies leverages proprietary AI to underwrite and distribute consumer and specialty credit via asset-backed securities. The company is profitable, producing positive free cash flow and trading at valuation multiples (EV/EBITDA ~8x, P/FCF ~7.2x) that leave room for upside if ABS volumes and partner flows continue to scale. This is a lon…
Cardinal Health is positioned to capture durable growth in specialty pharmaceuticals and precision medicine distribution. With a $54.66B market cap, meaningful free cash flow and a modest dividend, the stock offers a risk-reward setup for a long trade aimed at price normalization toward $270 as operational mix improves and radiopharmaceutical adopt…
Northern Oil & Gas (NOG) is offering a compelling mid-term swing trade: generous yield (~7%), low EV/EBITDA (3.1x) and analyst price targets near $48 suggest large upside from today’s $25.39. The case depends on sustained oil strength and stability in production growth; downside risk comes from negative cash flow, leverage and high short interest.
Ecovyst's sale of its Advanced Materials & Catalysts unit and the ensuing capital return/leverage reduction transform the company's risk profile. With a market cap near $1.13B, improving cash flow ($82.6M FCF) and attractive valuation metrics (EV/EBITDA ~10, EV/Sales ~1.76), the name looks set for a mid-term recovery. This trade targets a $14.00 up…
Semiconductor-driven risk-off has pushed software multiples sharply lower in 2026. ServiceNow's revenue durability, a $29 billion backlog, improving technicals and falling short interest argue the stock may be forming a bottom. I am downgrading the rating to Hold given elevated valuation vs. secular macro risk, but propose a disciplined long trade:…
TeraWulf's pivot from pure Bitcoin mining to utility-grade AI hosting has meaningfully lowered revenue volatility and improved margin visibility. The 20-year, $19 billion Anthropic lease and proceeds from a $450M JV sale materially de-risk the company’s capital plan. At $15.59 the market capitalizes a business with an enterprise value near $10.45B …
CoreWeave's selloff has created an actionable entry on a company that is finally demonstrating the execution the market has been waiting for. With revenue accelerating (112% quarterly growth to $2.6B), a $100B+ backlog, improving operating performance, and technical momentum intact, we upgrade CRWV and recommend a long trade. The setup requires str…
Mercury General (MCY) has shifted from a cycle-era laggard to a structurally healthier auto insurer. Underwriting improvements and favorable reserve development have pushed the combined ratio well below 100%, producing a swing to profit and robust free cash flow. The stock trades at single-digit multiples and under 1x sales — attractive on the numb…
Salesforce is misunderstood today. The sell-off has priced in a world where AI agents commoditize CRM, but the company is executing a more defensible strategy: selling governed, data-connected AI labor inside its platform while aggressively returning capital. With $41.5B revenue, strong free cash flow ($14.7B) and a sizeable $27B buyback last quart…
Denali's FDA approval of Avlayah and the sale of a $195 million Rare Pediatric Disease Priority Review Voucher materially derisk near-term funding and validates the company's TransportVehicle platform. Despite a recent setback in a Parkinson's program, the combination of platform validation, improving cash runway, and low leverage argues for a bull…
Sandisk announced investor-day targets that include ~80% gross margins, ~75% operating margins and ~50% free cash flow margins. Those aren’t just optimistic aspirations - the company’s cash generation, lack of debt, and direct exposure to AI memory demand make a solid case that elevated margins can persist beyond a typical NAND cycle. This trade id…
Nvidia is benefiting from an elongating GPU cycle driven by generative AI adoption, higher ASPs, and tight supply dynamics. We upgrade to Strong Buy and recommend a long trade with a clear entry at $850.00, a stop at $720.00 and a target of $1,100.00 over a 180-trading-day horizon. The trade balances upside from continued data-center strength again…
